- Home
- PLCE vs ARTV Comparison
PLCE vs ARTV Comparison
Compare PLCE & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- ARTV
- Stock Information
- Founded
- PLCE 1969
- ARTV 2019
- Country
- PLCE United States
- ARTV United States
- Employees
- PLCE N/A
- ARTV N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- ARTV
- Sector
- PLCE Consumer Discretionary
- ARTV
- Exchange
- PLCE Nasdaq
- ARTV NYSE
- Market Cap
- PLCE 128.9M
- ARTV 61.9M
- IPO Year
- PLCE 1997
- ARTV 2024
- Fundamental
- Price
- PLCE $5.76
- ARTV $1.94
- Analyst Decision
- PLCE Hold
- ARTV Strong Buy
- Analyst Count
- PLCE 1
- ARTV 7
- Target Price
- PLCE $9.00
- ARTV $19.17
- AVG Volume (30 Days)
- PLCE 411.4K
- ARTV 141.2K
- Earning Date
- PLCE 06-11-2025
- ARTV 05-08-2025
- Dividend Yield
- PLCE N/A
- ARTV N/A
- EPS Growth
- PLCE N/A
- ARTV N/A
- EPS
- PLCE N/A
- ARTV N/A
- Revenue
- PLCE $1,386,269,000.00
- ARTV N/A
- Revenue This Year
- PLCE N/A
- ARTV N/A
- Revenue Next Year
- PLCE N/A
- ARTV N/A
- P/E Ratio
- PLCE N/A
- ARTV N/A
- Revenue Growth
- PLCE N/A
- ARTV N/A
- 52 Week Low
- PLCE $4.77
- ARTV $1.78
- 52 Week High
- PLCE $19.74
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- PLCE 45.87
- ARTV N/A
- Support Level
- PLCE $5.60
- ARTV N/A
- Resistance Level
- PLCE $6.40
- ARTV N/A
- Average True Range (ATR)
- PLCE 0.37
- ARTV 0.00
- MACD
- PLCE 0.03
- ARTV 0.00
- Stochastic Oscillator
- PLCE 13.22
- ARTV 0.00
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).